Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1761-1770 of 2862 for cancer

Edit search filters
  1. A Study Using Gallium-68 PSMA-11 And C-11 Choline PET Imaging To Detect Metastatic Prostate Cancer In Patients

    Rochester, MN

  2. A Study Using Docetaxel With Or Without MLN1117 In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

    Rochester, MN

  3. Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone In Patients With Platinum Sensitive Ovarian Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. 177Lu-PSMA-617 Vs. Androgen Receptor-directed Therapy In The Treatment Of Progressive Metastatic Castrate Resistant Prostate Cancer

    Rochester, MN

  5. The Role Of Highly Selective Androgen Receptor (AR) Targeted Therapy In Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

    Scottsdale/Phoenix, AZ

  6. FES PET/CT In Predicting Response In Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

    Rochester, MN

  7. Safety And Tolerability Of TAR-200 In Subjects With Muscle-Invasive Bladder Cancer Who Are Unfit For Radical Cystectomy

    Scottsdale/Phoenix, AZ

  8. Testing The Addition Of Total Ablative Therapy To Usual Systemic Therapy Treatment For Limited Metastatic Colorectal Cancer, The ERASur Study

    Scottsdale/Phoenix, AZ

  9. Intensity-Modulated Radiation Therapy And Paclitaxel With Or Without Pazopanib Hydrochloride In Treating Patients With Anaplastic Thyroid Cancer

    Jacksonville, FL, Rochester, MN

  10. Gemcitabine Hydrochloride Alone Or With M6620 In Treating Patients With Recurrent Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer

    Rochester, MN

.

Mayo Clinic Footer